Biology subjects

Soneson, C.

Publications and source records attributed to Soneson, C..

6 recordsLinked to original sources

bioRxiv2018

A junction coverage compatibility score to quantify the reliability of transcript abundance estimates and annotation catalogs

Most methods for statistical analysis of RNA-seq data take a matrix of abundance estimates for some type of genomic features as their input, and consequently the quality of any obtained results are directly dependent on the quality of these abundances. Here, we present the junction coverage compatibility (JCC) score, which provides a way to evaluate the reliability of transcript-level abundance estimates as well as the accuracy of transcript annotation catalogs. It works by comparing the observed number of reads spanning each annotated splice junction in a genomic region to the predicted number of junction-spanning reads, inferred from the estimated transcript abundances and the genomic coordinates of the corresponding annotated transcripts. We show that while most genes show good agreement between the observed and predicted junction coverages, there is a small set of genes that do not. Genes with poor agreement are found regardless of the method used to estimate transcript abundances, and the corresponding transcript abundances should be treated with care in any downstream analyses.

bioinformatics↗

bioRxiv2018

diffcyt: Differential discovery in high-dimensional cytometry via high-resolution clustering

1High-dimensional flow and mass cytometry allow cell types and states to be characterized in great detail by measuring expression levels of more than 40 targeted protein markers per cell. Here, we present diffcyt, a new computational framework for differential discovery analyses in these datasets, based on (i) high-resolution clustering and (ii) empirical Bayes moderated tests adapted from transcriptomics. Our approach provides improved statistical performance, including for rare cell populations, along with flexible experimental designs and fast runtimes in an open-source framework.

bioinformatics↗

bioRxiv2018

Observation weights to unlock bulk RNA-seq tools for zero inflation and single-cell applications

Dropout events in single-cell transcriptome sequencing (scRNA-seq) cause many transcripts to go undetected and induce an excess of zero read counts, leading to power issues in differential expression (DE) analysis. This has triggered the development of bespoke scRNA-seq DE methods to cope with zero inflation. Recent evaluations, however, have shown that dedicated scRNA-seq tools provide no advantage compared to traditional bulk RNA-seq tools. We introduce a weighting strategy, based on a zero-inflated negative binomial (ZINB) model, that identifies excess zero counts and generates gene and cell-specific weights to unlock bulk RNA-seq DE pipelines for zero-inflated data, boosting performance for scRNA-seq.

bioinformatics↗

bioRxiv2017

zingeR: unlocking RNA-seq tools for zero-inflation and single cell applications

Dropout in single cell RNA-seq (scRNA-seq) applications causes many transcripts to go undetected. It induces excess zero counts, which leads to power issues in differential expression (DE) analysis and has triggered the development of bespoke scRNA-seq DE tools that cope with zero-inflation. Recent evaluations, however, have shown that dedicated scRNA-seq tools provide no advantage compared to traditional bulk RNA-seq tools. We introduce zingeR, a zero-inflated negative binomial model that identifies excess zero counts and generates observation weights to unlock bulk RNA-seq pipelines for zero-inflation, boosting performance in scRNA-seq differential expression analysis.

bioinformatics↗

bioRxiv2017

Bias, Robustness And Scalability In Differential Expression Analysis Of Single-Cell RNA-Seq Data

BackgroundAs single-cell RNA-seq (scRNA-seq) is becoming increasingly common, the amount of publicly available data grows rapidly, generating a useful resource for computational method development and extension of published results. Although processed data matrices are typically made available in public repositories, the procedure to obtain these varies widely between data sets, which may complicate reuse and cross-data set comparison. Moreover, while many statistical methods for performing differential expression analysis of scRNA-seq data are becoming available, their relative merits and the performance compared to methods developed for bulk RNA-seq data are not sufficiently well understood.\n\nResultsWe present conquer, a collection of consistently processed, analysis-ready public single-cell RNA-seq data sets. Each data set has count and transcripts per million (TPM) estimates for genes and transcripts, as well as quality control and exploratory analysis reports. We use a subset of the data sets available in conquer to perform an extensive evaluation of the performance and characteristics of statistical methods for differential gene expression analysis, evaluating a total of 30 statistical approaches on both experimental and simulated scRNA-seq data.\n\nConclusionsConsiderable differences are found between the methods in terms of the number and characteristics of the genes that are called differentially expressed. Pre-filtering of lowly expressed genes can have important effects on the results, particularly for some of the methods originally developed for analysis of bulk RNA-seq data. Generally, however, methods developed for bulk RNA-seq analysis do not perform notably worse than those developed specifically for scRNA-seq.

bioinformatics↗

bioRxiv2017

A general and powerful stage-wise testing procedure for differential expression and differential transcript usage

BackgroundReductions in sequencing cost and innovations in expression quantification have prompted an emergence of RNA-seq studies with complex designs and data analysis at transcript resolution. These applications involve multiple hypotheses per gene, leading to challenging multiple testing problems. Conventional approaches provide separate top-lists for every contrast and false discovery rate (FDR) control at individual hypothesis level. Hence, they fail to establish proper gene-level error control, which compromises downstream validation experiments. Tests that aggregate individual hypotheses are more powerful and provide gene-level FDR control, but in the RNA-seq literature no methods are available for post-hoc analysis of individual hypotheses.\n\nResultsWe introduce a two-stage procedure that leverages the increased power of aggregated hypothesis tests while maintaining high biological resolution by post-hoc analysis of genes passing the screening hypothesis. Our method is evaluated on simulated and real RNA-seq experiments. It provides gene-level FDR control in studies with complex designs while boosting power for interaction effects without compromising the discovery of main effects. In a differential transcript usage/expression context, stage-wise testing gains power by aggregating hypotheses at the gene level, while providing transcript-level assessment of genes passing the screening stage. Finally, a prostate cancer case study highlights the relevance of combining gene with transcript level results.\n\nConclusionStage-wise testing is a general paradigm that can be adopted whenever individual hypotheses can be aggregated. In our context, it achieves an optimal middle ground between biological resolution and statistical power while providing gene-level FDR control, which is beneficial for downstream biological interpretation and validation.

bioinformatics↗